Switch View
© ACCESSWIRE
31.10.2025
ISIN: US29415J1060
enVVeno Medical Corporation
NVNO
LISTED
NASDAQ
enVVeno Medical Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
- Cash and investments are sufficient to fund current operations through Q2 2027, not including VenoValve commercialization and the enVVe IDE study- Cash burn of $4.2 million in Q3 remains in line with projected quarterly range- Ongoing engagement with FDA for supervisory appeal of the VenoValve PMA decision with feedback expected by the end of 202...
Themefolio
Profiler
Peergroup
© Newsfile
31.10.2025
ISIN: CH1176493729
Bachem Holding AG
BANB
LISTED
SIX
Anne-Kathrin Stoller to Become New CEO at Bachem
News Preview
Bubendorf, Switzerland--(Newsfile Corp. - October 31, 2025) - Ad hoc announcement pursuant to Art. 53 LR Anne-Kathrin Stoller to become new CEO at Bachem Bachem (SIX: BANB) announced today that its Board of Directors has appointed Anne-Kathrin Stoller, currently Head of Bachem Americas and previously the company's long-s...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: JP3431300007
Nxera Pharma Co Ltd
45650
LISTED
XJPX
Nxera’s President & CEO to Participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference 2025
News Preview
Tokyo, Japan and Cambridge, UK, 31 October 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces its President & CEO, Chris Cargill, will participate in a ‘Fireside Chat’ at the Jefferies London Healthcare Conference on Monday, 17 November at 12:00 p.m. GMT / 7:00 a.m. ET / 9:00 p.m. JST. During the event, Mr. Cargill wil...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Leerverkaufsstatistiken, Hedge-Fund Aktivitäten und viele weitere nutzerwertige Informationen benutzerfreundlich aufbereitet
© Globe Newswire
31.10.2025
ISIN: US21833P3010
Corbus Pharmaceuticals Holdings Inc
CRBP
LISTED
NASDAQ
Corbus Pharmaceuticals Announces Pricing of Public Offering
News Preview
NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), an oncology and obesity company, today announced the pricing of an underwritten public offering of 4,744,231 shares of its common stock at a public offering price of $13.00 per share, and, in lieu of common stock to...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
31.10.2025
ISIN: JP3431300007
Nxera Pharma Co Ltd
45650
LISTED
XJPX
Nxera Pharma Receives a Manufacturing Approval Partial Amendment Regarding the Addition of a Manufacturing Site in Asia for QUVIVIQ® 25 and 50 mg
News Preview
Tokyo, Japan and Cambridge and London, UK, 31 October 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) announces that Nxera Pharma Japan Co., Ltd. (a wholly owned subsidiary of the Company) has received a manufacturing approval partial amendment with respect to QUVIVIQ® (daridorexant) 25 and 50 mg (“the Product”). Daridorexant was...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: JP3431300007
Nxera Pharma Co Ltd
45650
LISTED
XJPX
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2025
News Preview
Tokyo, Japan and Cambridge, UK, 31 October 2025 – Nxera Pharma (“the Company” or “Nxera”; TSE: 4565) provides an update on operational activities and reports its consolidated results for the third quarter and nine months ended 30 September 2025. The full report can be found here....
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Announces Pricing of $250 Million Public Offering of Common Stock
News Preview
Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, today announced the pricing of an underwritten public offering of 13,700,000 shares of its common stock at a price to the p...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: US35104E1001
4D Molecular Therapeutics Inc
FDMT
LISTED
NASDAQ
4DMT Announces Exclusive License Agreement with Otsuka Pharmaceutical Co., Ltd. for Development and Commercialization of 4D-150 in Asia-Pacific
News Preview
EMERYVILLE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced a strategic partnership...
Themefolio
Profiler
Peergroup
© BusinessWire
31.10.2025
ISIN: JP3475350009
Daiichi Sankyo Co Ltd
45680
LISTED
XJPX
DESTINY-Lung06 Phase 3 Trial of ENHERTU® Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic Non-Squamous Non-Small Cell Lung Cancer
News Preview
The first patient has been dosed in the DESTINY-Lung06 phase 3 trial evaluating ENHERTU® (trastuzumab deruxtecan) plus pembrolizumab versus pembrolizumab, platinum-based chemotherapy and pemetrexed as a first-line treatment in patients with unresectable, locally advanced or metastatic HER2 overexpressing and PD-L1 TPS <50% non-squamous non-smal...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.10.2025
ISIN: KYG4783B1032
Innocare Pharma Limited
9969
LISTED
HKSE
InnoCare Announces First Patient Dosed in Clinical Trial of Novel ADC ICP-B794 in China
News Preview
ICP-B794 has demonstrated superior anti-tumor activity in animal models, and exhibited significant tumor-killing effects even in large tumors....
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ:...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
AVTR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
News Preview
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) and reminds investors of the December 29, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.
Faruqi & F...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© BusinessWire
30.10.2025
ISIN: US5171251003
Larimar Therapeutics Inc
LRMR
LISTED
NASDAQ
Rosen Law Firm Encourages Larimar Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – LRMR
News Preview
Why: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Larimar Therapeutics, Inc. (NASDAQ: LRMR) resulting from allegations that Larimar Therapeutics may have issued materially misleading business information to the investing public.
So What: If you purchased Lari...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US6402683063
Nektar Therapeutics
NKTR
LISTED
NASDAQ
Nektar Therapeutics to Participate in the Jefferies Global Healthcare Conference in London
News Preview
SAN FRANCISCO, Oct. 30, 2025 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that company management will be webcasting its participation in the Jefferies Global Healthcare Conference being held November 17-20, 2025 in London....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US58468P2065
MediciNova Inc
MNOV
LISTED
NASDAQ
MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
News Preview
Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001 and its metabolite MN-002) has influence on cholesterol metabolism in patients Study published in the Journal of Atherosclerosis and Thrombosis demonstrates tipelukast (MN-001 and its metabolite MN-002) has influence on cholesterol metabolism in patient...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: CA10919W4056
Bright Minds Biosciences Inc.
DRUG
LISTED
NASDAQ
Bright Minds Biosciences to Present at Upcoming Conferences
News Preview
NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bright Minds Biosciences, Inc. (“Bright Minds,” “BMB” or the “Company”) (NASDAQ: DRUG), a pioneering company focused on developing highly selective 5-HT2 agonists for the treatment of drug-resistant epilepsy, depression, and other central nervous system (CNS) disorders, today announced that the Company...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: NL0015002CX3
Qiagen NV
QGEN
LISTED
NYSE
QIAGEN Launches New Automated Sexual Assault Sample Processing Kit at ISHI 2025
News Preview
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the EZ2 DNA Investigator Sep&Prep Kit, a fully automated solution for processing sexual assault samples, at the upcoming International Symposium on Human Identification 2025 (ISHI) from November 3-6 in Palm Beach, Florida.
Developed specifically for forensi...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO
News Preview
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Soleno Therapeutics, Inc. (NASDAQ: SLNO) resulting from allegations that Soleno Therapeutics may have issued materially misleading business information to the investing public.
So What: If you purchased S...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 30, 2025 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an increase to its non-b...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: CA09076M2004
BioVaxys Technology Corp.
BIOV
LISTED
CSE
BIOVAXYS ANNOUNCES UPSIZING OF LIFE OFFERING OF UP TO $2M
News Preview
// NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES //
VANCOUVER, BC, Oct. 30, 2025 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces an increase to its non-brokered...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US09073N3008
Streamex Exchange Corp.
STEX
LISTED
NASDAQ
Streamex Corp. (NASDAQ: STEX) Announces Nasdaq Approval for Continued Listing on Nasdaq Capital Market & Shareholder Meeting on November 4, 2025
News Preview
LOS ANGELES, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), an institutional commodity tokenization company, today announced that it has received formal approval from Nasdaq for continued listing of its shares of common stock on the Nasdaq Capital Market under the ticker symbol “STEX.”...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US86150R1077
Stoke Therapeutics Inc
STOK
LISTED
NASDAQ
Stoke Therapeutics to Host Webcast and Conference Call to Discuss Third Quarter 2025 Business and Financial Updates
News Preview
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today announced that manag...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US2036681086
Community Health Systems Inc
CYH
LISTED
NYSE
Community Health Systems Announces Definitive Agreement to Sell Ownership Interests in Clarksville, Tennessee, Hospital to Vanderbilt University Medical Center
News Preview
Community Health Systems, Inc. (NYSE: CYH) announced today that subsidiaries of the Company have entered into a definitive agreement to sell their 80% ownership interests in two joint ventures, which respectively own and operate 270-bed Tennova Healthcare - Clarksville and certain ancillary businesses located in Clarksville, Tennessee, to subsidia...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US81619Q1058
Select Medical Holdings Corp
SEM
LISTED
NYSE
Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2025 and Cash Dividend
News Preview
MECHANICSBURG, Pa., Oct. 30, 2025 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its third quarter ended September 30, 2025, and the declaration of a cash dividend.
For the third quarter ended September 30, 2025,...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US5165441032
Lantheus Holdings Inc
LNTH
LISTED
NASDAQ
LNTH Deadline: LNTH Investors Have Opportunity to Lead Lantheus Holdings, Inc. Securities Fraud Lawsuit
News Preview
NEW YORK, Oct. 30, 2025 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lantheus Holdings, Inc. (NASD...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
Edwards Lifesciences Announces CFO Transition Plan
News Preview
Edwards Lifesciences (NYSE: EW) today announced that Scott Ullem, the company’s chief financial officer, has decided to transition from his role by midyear 2026. While the company initiates a selection process to appoint a new CFO, this planned transition will enable continuity and a smooth transfer of responsibilities. Following the appointment o...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US00846U1016
Agilent Technologies Inc
A
LISTED
NYSE
Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24
News Preview
Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2025 after the stock market closes on Monday, Nov. 24. The company will host a conference call to discuss the results at 1:30 p.m. PST the same day.
To join the listen-only conference call webcast, click the link on the Events section of Agil...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: CA4990531069
Knight Therapeutics Inc
GUD
LISTED
TSX
Knight Therapeutics Announces Launch of JORNAY PM™ in Canada
News Preview
MONTREAL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of JORNAY PM™ (methylphenidate HCI extended-release capsules) in Canada. JORNAY PM™ is an extended-release formulation of methylphenidate, a stimulant medication for the t...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: CH1384053976
NLS Pharmaceutics AG
NLSP
LISTED
NASDAQ
NLS Pharmaceutics Ltd. and Kadimastem Ltd. Announce Completion of Merger
News Preview
Combined Company Re-Named NewcelX Ltd., to Commence Trading on the Nasdaq Capital Market on October 31, 2025 under the Ticker Symbol "NCEL"
ZURICH and NESS ZIONA, Israel , Oct. 30, 2025 /PRNewswire/ -- ...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US28176E1082
Edwards Lifesciences Corp.
EW
LISTED
NYSE
Edwards Lifesciences Reports Third Quarter Results
News Preview
Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended September 30, 2025.
Recent Highlights
Q3 sales grew 14.7% to $1.55 billion, or 12.6% adjusted1, with strength across all product groups
Q3 TAVR sales grew 12.4%; constant currency1 sales grew 10.6%
Q3 TMTT sales of $145.2 million, growth driven by PAS...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US2358511028
Danaher Corp
DHR
LISTED
NYSE
DHR Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Danaher Corporation – DHR
News Preview
Rosen Law Firm, a global investor rights law firm, continues to investigate potential breaches of fiduciary duties by the directors and officers of Danaher Corporation (NYSE: DHR).
If you currently own shares of Danaher stock, please visit the firm’s website at https://rosenlegal.com/submit-form/?case_id=17717 for more information. You may also...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: BE0974358906
Nyxoah S.A.
NYXH
LISTED
NASDAQ
Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025
News Preview
Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US21217B1008
Contineum Therapeutics, Inc.
CTNM
LISTED
NASDAQ
Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
News Preview
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation and immunology (NI&I) indications, today reported its third-quarter 2025 financial results and affirmed its key clinical development milestones....
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: IE00B91XRN20
Prothena Corporation PLC
PRTA
LISTED
NASDAQ
Prothena to Report Third Quarter 2025 Financial Results on November 6
News Preview
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced that it will report its third quarter and first nine months of 2025 financial results on Thursday November 6, 2025, after the close of the U.S. financia...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US67080N1019
Nuvation Bio Inc
NUVB
LISTED
NYSE
Nuvation Bio to Participate in Upcoming Investor Conferences
News Preview
Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that David Hung, M.D., Founder, President, and Chief Executive Officer of Nuvation Bio, and Philippe Sauvage, Chief Financial Officer of Nuvation Bio, will participate in three upcoming investor confere...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US00653Q1022
Adapthealth Corp
AHCO
LISTED
NASDAQ
AdaptHealth Corp. to Participate in Upcoming Investor Conference
News Preview
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the UBS Global Healthcare Conference, being held in Palm Beach Gardens, FL, on Tuesd...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US6907321029
Owens & Minor Inc
OMI
LISTED
NYSE
Owens & Minor Reports Third Quarter 2025 Financial Results
News Preview
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the third quarter ended September 30, 2025. Unless otherwise noted, the results herein reflect the Company’s continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations.
“Our recent announcement on the sa...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US02081G2012
Alphatec Holdings Inc
ATEC
LISTED
NASDAQ
ATEC Reports Third Quarter 2025 Financial Results And Raises Full-Year Guidance
News Preview
Alphatec Holdings, Inc. (Nasdaq: ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended September 30, 2025, and recent corporate highlights.
Third Quarter 2025 Financial Results
Quarter Ended
September 30, 2025...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US81749D1072
Sera Prognostics Inc
SERA
LISTED
NASDAQ
SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF THIRD QUARTER FISCAL YEAR 2025 FINANCIAL RESULTS ON NOVEMBER 13, 2025
News Preview
SALT LAKE CITY, Oct. 30, 2025 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced it will report third quarter fiscal year 2025 financial res...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US9224751084
Veeva Systems Inc
VEEV
LISTED
NYSE
Veeva to Release Fiscal 2026 Third Quarter Results on November 20, 2025
News Preview
PLEASANTON, Calif., Oct. 30, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its third quarter ending October 31, 2025 after market close on November 20, 2025. Veeva will host a conference call and webcast that day at 2:00 p.m. PT (5:00 p.m. ET) to discuss its financial results...
Themefolio
Profiler
Peergroup
© PR Newswire
30.10.2025
ISIN: US4523271090
Illumina Inc
ILMN
LISTED
NASDAQ
Illumina Reports Financial Results for Third Quarter of Fiscal Year 2025
News Preview
Revenue of $1.08 billion for Q3 2025, flat compared to Q3 2024 on both a reported and constant currency basis
GAAP operating margin of 21.0% and non-GAAP operating margin of 24.5% for Q3 2025
GAAP diluted EPS of $0.98 and non-GAAP diluted EPS of $1.34 for Q3 2025...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US3755581036
Gilead Sciences Inc
GILD
LISTED
NASDAQ
Gilead Sciences Announces Third Quarter 2025 Financial Results
News Preview
Gilead Sciences, Inc. (Nasdaq: GILD) announced today its third quarter 2025 results of operations.
“We continue to deliver on Gilead's robust portfolio with a strong start for Yeztugo, rapidly growing uptake of Biktarvy, Descovy and Livdelzi, and positive data for Trodelvy in 1L metastatic triple negative breast cancer,” said Daniel O’Day, Gilea...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US2521311074
Dexcom Inc
DXCM
LISTED
NASDAQ
Dexcom Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Guidance
News Preview
DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights:
Revenue grew 22% year-over-year to $1.209 billion on a reported basis and 20% year-over-year on an organic1 basis.
U.S. revenue grew 21% and international revenue grew 22% on a report...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: CA60255C8850
Mind Medicine (MindMed) Inc
MNMD
LISTED
NASDAQ
MindMed to Report Q3 2025 Financial Results on November 6, 2025
News Preview
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that it will host a live webcast at 4:30 p.m. EST on Thursday, November 6, 2025 to report financial results for the third quarter ended Septem...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US03969F1093
Arcus Biosciences Inc
RCUS
LISTED
NYSE
Arcus Biosciences Announces Commencement of Public Offering of Common Stock
News Preview
Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, inflammatory and autoimmune diseases, today announced that it has commenced an underwritten public offering of its common stock. All of the shares of common stoc...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Reports Third Quarter 2025 Financial Results
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its third quarter 2025 financial results and provided a corporate update.
“We delivered outstanding commercial performance in the third quarter, reflecting the growing role of FILSPARI as a foundational therapy in IgAN. This success underscores the strength of our commercial execution and...
Themefolio
Profiler
Peergroup
© BusinessWire
30.10.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Avantor, Inc. (AVTR) Investors: Kessler Topaz Meltzer & Check, LLP Files a Securities Fraud Class Action Lawsuit Against Avantor, Inc. and Encourages Investors With Substantial Losses to Contact the Firm
News Preview
The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that the firm has filed a securities fraud class action lawsuit against Avantor, Inc. (NYSE: AVTR) (“Avantor” or the “Company”) on behalf of investors who purchased or acquired Avantor common stock between March 5, 2024, and October 28, 2025, inclusive (the “Class Period”). T...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US75340L1044
Rapid Micro Biosystems Inc
RPID
LISTED
NASDAQ
Rapid Micro Biosystems to Participate in the Stifel 2025 Healthcare Conference
News Preview
LEXINGTON, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced that the Company will participate i...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US21833P3010
Corbus Pharmaceuticals Holdings Inc
CRBP
LISTED
NASDAQ
Corbus Pharmaceuticals Announces Proposed Public Offering
News Preview
NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (Nasdaq: CRBP) (“Corbus” or the “Company”), an oncology and obesity company, today announced that it plans to offer and sell shares of its common stock or, in lieu of common stock to certain investors, pre-funded warrants to purchase shares of its common stock...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: FR0010417345
Dbv Technologies SA
DBV
LISTED
EURONEXT
DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors
News Preview
Châtillon, France, October 30, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US68062P1066
Olema Pharmaceuticals, Inc.
OLMA
LISTED
NASDAQ
Olema Oncology to Present Trial-in-Progress Poster for Phase 3 OPERA-02 Trial of Palazestrant Plus Ribociclib at SABCS 2025
News Preview
SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced it will present a trial-in-progress poster for the Pha...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US18914F1030
Clover Health Investments Corp
CLOV
LISTED
NASDAQ
Primary Care Physician Use of Counterpart Assistant (CA) Technology Associated With Earlier Diagnosis And Less Frequent Hospitalization In Underserved Populations
News Preview
New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease. New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US04317A1079
Artiva Biotherapeutics, Inc.
ARTV
LISTED
NASDAQ
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November
News Preview
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US5147661046
Lifecore Biomedical Inc
LFCR
LISTED
NASDAQ
Lifecore Biomedical to Report Financial Results for the Three Months Ended September 30, 2025, on November 6, 2025
News Preview
Webcast Scheduled for Thursday, November 6 at 4:30 p.m. Eastern Webcast Scheduled for Thursday, November 6 at 4:30 p.m. Eastern...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US45782T1051
INmune Bio, Inc.
INMB
LISTED
NASDAQ
INmune Bio Inc. Announces Third Quarter 2025 Results and Provides Business Update
News Preview
Company to Host Conference Call Today, October 30, at 4:30pm ET Company to Host Conference Call Today, October 30, at 4:30pm ET...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US4500561067
iRhythm Technologies Inc
IRTC
LISTED
NASDAQ
iRhythm Technologies Announces Third Quarter 2025 Financial Results
News Preview
SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, today reported financial results for the three months ended September 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US75943R1023
Relay Therapeutics Inc
RLAY
LISTED
NASDAQ
Relay Therapeutics to Announce Third Quarter 2025 Financial Results and Corporate Highlights on November 6, 2025
News Preview
CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2025 financial results and corporate highlights after the U.S. financial m...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US8636671013
Stryker Corp
SYK
LISTED
NYSE
Stryker reports third quarter 2025 operating results
News Preview
Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025:...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US7611521078
Resmed Inc
RMD
LISTED
NYSE
Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026
News Preview
Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com...
Themefolio
Profiler
Peergroup
© Globe Newswire
30.10.2025
ISIN: US5898891040
Merit Medical Systems Inc
MMSI
LISTED
NASDAQ
Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance
News Preview
Highlights†...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
